MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 9, 2011, Pages 1887-1895

  Li, Xiaohua ^a   Zhang, Ying ^b   Shi, Yongquan ^a   Dong, Guanglong ^a   Liang, Jie ^a   Han, Ying ^a   Wang, Xin ^a   Zhao, Qingchuan ^a   Ding, Jie ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Metastasis; MiR 107

Indexed keywords

DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MICRORNA; MIRN107 MICRORNA, HUMAN; RIBONUCLEASE III;

3' UNTRANSLATED REGION; ANIMAL; ARTICLE; CANCER INVASION; CELL MOTION; CELL STRAIN HEK293; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; METASTASIS; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOLOGY; PHENOTYPE; PROGNOSIS; STOMACH TUMOR; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL MOVEMENT; DEAD-BOX RNA HELICASES; DOWN-REGULATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HEK293 CELLS; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENES; PHENOTYPE; PROGNOSIS; RIBONUCLEASE III; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; UP-REGULATION;

MUS MUSCULUS;

EID: 80052178588     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01194.x     Document Type: Article

References (32)

1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pyloriinfection and the development of gastric cancer. N Engl J Med. 2001; 345: 784-9.
2. Li X, Zhang Y, Ding J, et al. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010; 59: 579-85.
3. Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 350-5.
4. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002; 99: 15524-9.
5. O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435: 839-43.
6. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008; 13: 272-86.
7. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006; 103: 2257-61.
8. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435: 834-8.
9. Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010; 28: 1721-6.
10. Gupta GP, Nguyen DX, Chiang AC, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature. 2007; 446: 765-70.
11. Pan Y, Zhao L, Liang J, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J. 2006; 20: 1886-8.
12. Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell. 2003; 115: 787-98.
13. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005; 37: 495-500.
14. Moll F, Millet C, Noel D, et al. Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. FASEB J. 2006; 20: 240-50.
15. Patrick DL, Ramsey SD, Spencer AC, et al. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care. 2001; 39: 413-24.
16. Bensenor LB, Barlan K, Rice SE, et al. Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants. Proc Natl Acad Sci USA. 2010; 107: 7311-6.
17. Li W, You L, Cooper J, et al. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell. 2010; 140: 477-90.
18. Morales FC, Molina JR, Hayashi Y, et al. Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma. Neuro Oncol. 2010; 12: 528-39.
19. Kumar MS, Pester RE, Chen CY, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 2009; 23: 2700-4.
20. Zheng ZH, Sun XJ, Fu WN, et al. Decreased expression of DICER1 in gastric cancer. Chin Med J (Engl). 2007; 120: 2099-104.
21. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002; 2: 563-72.
22. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol. 2002; 12: 89-96.
23. Hiratsuka M, Iwanaga T, Furukawa H, et al. [Important prognostic factors in surgically treated gastric cancer patients]. Gan To Kagaku Ryoho. 1995; 22: 703-8.
24. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87: 236-42.
25. Garzon R, Fabbri M, Cimmino A, et al. MicroRNA expression and function in cancer. Trends Mol Med. 2006; 12: 580-7.
26. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-69.
27. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005; 65: 3509-12.
28. Nelson PT, Wang WX. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis. 2010; 21: 75-9.
29. Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008; 28: 1213-23.
30. Yamakuchi M, Lotterman CD, Bao C, et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA. 2010; 107: 6334-9.
31. Takahashi Y, Forrest AR, Maeno E, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One. 2009; 4: e6677.
32. Lee KH, Lotterman C, Karikari C, et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 2009; 9: 293-301.